Estrogen metabolites as bioreactive modulators of tumor initiators and promoters

Advances in Experimental Medicine and Biology

Volumn 387, Issue , 1996, Pages 285-296

  Bradlow, Leon ^a   Telang, Nitin T ^a   Osborn, Michael P ^a  

^a Strang Cancer Research Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL;

BIOREACTOR; BREAST CANCER; CARCINOGENESIS; CELL GROWTH; CONFERENCE PAPER; ENDOMETRIUM CANCER; ESTROGEN SYNTHESIS; HORMONE SENSITIVITY; HYDROXYLATION; METABOLITE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0029783228     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4757-9480-9_37     Document Type: Conference Paper

References (52)

1. Beatson, G., On the treatment of inoperable cases of breast cancer by oophorectomy Lancet 2: 104-107 1898
2. Miyairi, S and Fishman, J. Radiometric analysis of oxidative reactions in aromatization by placental microsomes J. Biol. Chem. 260: 320-325 1985
3. Fishman, J., Bradlow, H.L., Schneider, J., Anderson, K.E., and Kappas, A. (1980). Radiometric analysis of biological oxidation in man: Sex differences in estradiol metabolism. Proc. Natl. Acad. Sci. 77: 4957-4960.
4. Bradlow, H.L., Michnovicz, J.J., Telang, N.T., Osborne, M.P. and Goldin B.R. Diet, oncogenes and tumor viruses as modulators of estrogen metabolism in vivo and in vitro. Cancer Detect Prev S16: 35-42, 1992.
5. Guengerich. FP Mechanism-based inactivation of human liver microsomal cytochrome P450IIA4 by gestodene Chemical Research in Toxicology 3:363-371 1990
6. Galbraith R.A. and Michnovicz, J.J. (1989). The effects of cimetidine on the oxidative metabolism of estradiol. New Engl. J. Med. 321 269-274.
7. Anderson, K.E., Kappas, A., Conney, A.H., Bradlow, H.L., and Fishman, J. (1984). The influence of dietary protein and carbohydrate on the principal oxidative biotransformations of estradiol in normal subjects. J. Clin. Endo. Metab. 59 103-107.
8. Gierthy, J.F., Lincoln, D.W. II, Kampcik, S.J., Dickerman, H.W., Bradlow, H.L., Niwa, T., and Swaneck, G.E. (1988). Enhancement of 2- and 16α-estradiol hydroxylation in MCF-7 human breast cancer cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem. Biophys, Res. Commun. 157 515-520.
9. Bradlow, H.L., Michnovicz, J.J., Telang, N.T. and Osborne, M.P. 1991 Effect of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice. Carcinogenesis 12:1571-1574, 1991.
10. Sepkovic, D.W., Bradlow, H.L., Michnovicz, J.J., Murtezani, S., Levy, I. and Osborne, M.P. Catechol estrogen production in rat microsomes after treatment with indole-3-carbinol, ascorbigen, or β-napthoflavone: A comparison of stable isotope dilution gas chromatography-mass spectrometry and radiometric methods. Steroids 59: 318-323, 1994.
11. Lustig, R., Hershcopf, R.J. and Bradlow, H.L. The impacts of body weight and diet on estrogen metabolism and estrogen-dependent disease. In Adipose Tissue and Reproduction ed. Frisch, R. Karger Press, Zurich, pp. 119-132, 1989.
12. Gordon J, Cantrall WP, Albers HJ, Mauer S, and Stolar SM. Steroids and lipid metabolism. The hypocholesteremic effect of estrogen metabolites. Steroids 4: 267-91 (1964).
13. Schneider, J., Huh, M.M., Bradlow, H.L. and Fishman, J. Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells. J Biol Chem 259: 4840-4845, 1984.
14. Zhu, BT, Ezelb, EL Liehr, JG. Catechol O-methyl transferase catalyzes O-methylation of mutagenic flavonoids: Metabolic inactivation as a possible reason for their lack of carcinogenicity in vivo J. Biol. Chem. 269: 292-299 1994.
15. Li, S.A., Li, J.J., Metabolism of moxestrol in the hamster kidney: significance for estrogen carcinogenesis in Hormonal Carcinogenesis, Li, J.J., Nandi, S., and Li, S.A., eds. Springer-Verlag New york, p 110 1992.
16. Shen, Z, Lie, J., Wells, R.L., and Elkind, M.M. CDNA cloning, sequence analysis, and induction by aryl hydrocarbons of a murine cytochroome P450 gene Cyp1B1 DNA Cell Biol 12: 763-9 1994
17. Bradlow, HL Unpublished observations from this laboratory'
18. Zhu, B.T., Bui, Q.D., Weisz, J, Liehr, J.C. Conversion of estrone to 2- and 4-hydroxyestrone by hamster liver and kidney microsomes: Implications for the mechanism of estrogen induced carcinogenesis. Endocrinol. 135: 1772-1779 1994.
19. Jellinck P.H. and Bradlow H.L. Peroxidase-catalysed displacement of tritium from regio-specifically labeled estradiol and 2.-hydroxyestradiol. J Steroid Biochem 35: 705-710, 1990.
20. Musey, P.I., Collins, D.C., Bradlow, H.L., Gould, K.G., and Preedy, J.K.R. Effect of diet on oxidation of 17β-estradiol in vivo. J. Clin. Endo. Metab 65 792-796 1987.
21. Osborne, M.P., Bradlow, H.L., Wong, G.Y. and Telang, N.T. Increase in the extent of estradiol 16α-hydroxylation in human breast tissue: A potential biomarker of breast cancer risk. J Natl Cancer Inst 85: 1917-1920, 1993.
22. Auborn K.J., Woodworth, C., DiPaolo, J.A. and Bradlow, H.L. The interaction between HPV infection and estrogen metabolism in cervical carcinogenesis Inst. J. Cancer 49: 867-869, 1991.
23. Bradlow, H.L., Hershcopf, R.J., Martucci, C.P., and Fishman, J. Estradiol 16α-hydroxylation in the mouse correlates with mammary tumor incidence and presence of MMTV: a possible model for hormonal etiology of breast cancer in humans. Proc. Natl. Acad. Sci. USA 82 6295-6299 1985.
24. Suto, A., Bradlow, H.L., Wong, G.Y., Osborne, M.P. and Telang, N.T. Persistent estrogen responsiveness of Ras oncogene-transformed mouse mammary epithelial cells. Steroids 57: 262-268, 1992.
25. Telang, N.T., Arcuri, F., Granata, O.M., Bradlow, H.L., Osborne, M.P. and Castagnetta, L. Alteration of estradiol metabolism in myc oncogene-transfected mouse mammary epithelial cells. Breast Cancer Res Treat, 1994 in press.
26. Han, X, Liehr, JC 8-Hydroxylation of guanine bases in kidney and liver DNA of hamsters treated with estradiol: Role of free radicals in estrogen induced carcinogenesis Cancer Res. 54: 5515-5517 1994.
27. Suto, A., Bradlow, H.L., Wong, G.Y., Osborne, M.P., and Telang, N.T. Experimental down-regulation of intermediate biomarkers of carcinogenesis in mouse mammary epithelial cells. Breast Cancer Res Treat 27: 193-202 1993.
28. Dwivedy, I., Devaneson, P., Cremonesi, P., Rogan, E., and Cavalieri, E. Synthesis and Characterization of Estrogen 2,3- and 3,4-quinones. Comparison of DNA adducts formed by the quinones versus Horseradish peroxidase-activated catechol estrogens. Chem. Res Toxicol 9: 828-833 1992.
29. Li, JJ, Li, SA, Oberley, TG, and Parsons, JA 1995, Carcinogenic Activities of Various Steroidal and Nonsteroidal Estrogens in the Hamster Kidney: Relation to Hormonal Activity and Cell Proliferation. Cancer Res 55 4347-4351.
30. Bradlow HL, Michnovicz JJ, Telang NT, et al: Diet, oncogenes and tumor viruses as modulators of estrogen metabolism in vivo and in vitro. Cancer Detect Prev S16: 35-42, 1992
31. Kojima T, Tanaka T, Mori M: Chemoprevention of spontaneous endometrial cancer in female Donryku rats by dietary indole-3-carbinol Cancer Res. 54:1446-1449, 1994
32. Malloy, V, Bradlow, HL, Matias, J, Orentreich, N: Further studies on chemoprevention of mammary tumors with indole-3-carbinol Terra Symposium on Estrogens 1991. Abst #24
33. Grubbs C, Steele VE, Casebolt T, et al: Chemoprevention of chemically induced mammary carcinogenesis by indole-3-carbinol AACR Meeting 1994 Abst #1305
34. Neufield L, Goldsmith A, Bradlow HL, Auborn K: Estrogen metabolism and human papilloma virus-induced tumors of the larynx: Chemoprophylaxis with indole-3-carbinol. Anticancer Res. 13: 227-234 1993.
35. Schneider, J., Kinne, D., Fracchia, A., Pierce, V., Anderson, K.E., Bradlow, H.L. and Fishman, J. Abnormal oxidative metabolism of estradiol in women with breast cancer. Proc Natl Acad Sci USA, 79: 3047-3051, 1982.
36. Osborne M.P., Karmali R.A., Hershcopf R.J., Bradlow H.L., Kourides I.A., Williams W.R., Rosen P.P. and Fishman J. Omega-3 fatty acids: Modulation of estrogen metabolism and potential for breast cancer prevention. Cancer Invest 8: 629-631, 1988.
37. Bradlow, H.L., Hershcopf, R.J., Martucci, C.P. and Fishman, J. Estradiol 16α-hydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumor virus: A possible model for the hormonal etiology of breast cancer in humans. Proc Natl Acad Sci USA, 82: 6295-6299, 1985.
38. Telang, N.T., Narayanan, R., Bradlow, H.L. and Osborne, M.P. Coordinated expression of intermediate biomarkers for tumorigenic transformation in Ras-transfected mouse mammary epithelial cells. Breast Cancer Res Treat 18: 155-163, 1991.
39. Telang, N.T., Kurihara, H., Wong, G.T.C., Bradlow, H.L., Osborne, M.P. Preneoplastic transformation in mouse mammary tissue: Identification and validation of intermediate biomarkers for chemoprevention Anticancer Res. 11: 1021-1028 1991
40. Telang, N.T., Bradlow, H.L. and Osborne, M.P. Molecular and endocrine biomarkers in noninvolved breast: Relevance to cancer chemoprevention. J Cell Biochem S 16 G: 161-169, 1992.
41. Telang, N.T., Suto, A., Wong, G.Y., Osborne, M.P. and Bradlow, H.L. Estrogen metabolite 16α-hydroxyestrone induces genotoxic damage and aberrant cell proliferation in mouse mammary epithelial cells in culture. J Natl Cancer Inst 84: 634-638, 1992.
42. Private communication from Dr. Suto.
43. Anderson, K.E., Kappas, A., Conney, A. H., Bradlow, H.L. and Fishman, J. The influence of dietary protein and carbohydrate on the principal oxidative biotransformations of estradiol in normal subjects. J Clin Endocrinol Metab 59: 103-107, 1984.
44. Bradlow, H.L., Michnovicz, J.J., Wong, G.Y.C., Halper, M.P., Miller, D. and Osborne, M.P. Long term responses of women to indole-3-carbinol or a high fiber diet. Cancer Epidemiol Biomarkers Prevention 3 591-595, 1994.
45. Lustig, R.H., Bradlow, H.L. and Fishman, J. Estrogen metabolism in disorders of nutrition and dietary composition. In: The Menstrual Cycle and Its Disorders, eds. H.M. Pirke, J. Wuttke and U. Schweiger, Springer-Verlag, Berlin, Heidelberg, pp 119-132, 1989.
46. Snow, R., Barbieri, R., and Frisch, R., Estrogen 2-hydroxylase oxidation and menstrual function among elite oarswomen J. Clin.Endocrinol. and Metab., 69: 369-376 1991.
47. Michnovicz, J.J., Hershcopf, R.J., Naganuma, H., Bradlow, H.L. and Fishman, J. Increased 2-hydroxylation of estradiol as a possible mechanism for the antiestrogenic effect of cigarette smoking. N Engl J Med 315: 1305-1309, 1986.
48. Gierthy, J.F., Lincoln, D.W. II, Kampcik, S.J., Dickerman, H.W., Bradlow, H.L., Niwa, T. and Swaneck, G.E. Induction of human breast cancer cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem Biophys Res Commun 157: 50-55 1988.
49. Niwa, T., Swaneck, G. and Bradlow, H.L. Alterations in estradiol metabolism in MCF-7 cells induced by treatment with indole-3-carbinol and related compounds. Steroids 59 523-527 1994.
50. Bradlow, H.L., Michnovicz, J.J., Telang, N.T. and Osborne, M.P. Effect of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice. Carcinogenesis 12: 1571-1574, 1991.
51. Michnovicz, JJ and Bradlow, HL. Induction of estradiol metabolism by indole-3-carbinol in humans J. Natl Cancer Instit. 82: 947-951 1990.
52. Michnovicz, J.J. and Bradlow, H.L. Altered estrogen metabolism and excretion in humans following consumption of indole-3-carbinol. Nutr Cancer 16: 59-66, 1991.